ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice by Alharbi, N, Regalado, E, Thompson, C, Kupke, A, Wells, D, Sloan, M, Grehan, K, Temperton, N, Lambe, T, Warimwe, G, Becker, S, Hill, A, Gilbert, S

Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels by Alharbi, N, Qasim, I, Almasoud, A, Aljami, H, Alenazi, M, Alhafufi, A, Aldibasi, O, Hashem, A, Kasem, S, Albrahim, R, Aldubaib, M, Almansour, A, Temperton, N, Kupke, A, Becker, S, Abu-Obaidah, A, Alkarar, A, Yoon, I, Azhar, E, Lambe, T, Bayoumi, F, Aldowerij, A, Ibrahim, O, Gilbert, S, Balkhy, H

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 t... by Folegatti, PM, Bittaye, M, Flaxman, A, Lopez, FR, Bellamy, D, Kupke, A, Mair, C, Makinson, R, Sheridan, J, Rohde, C, Halwe, S, Jeong, Y, Park, Y-S, Kim, J-O, Song, M, Boyd, A, Tran, N, Silman, D, Poulton, I, Datoo, M, Marshal, J, Themistocleous, Y, Lawrie, A, Roberts, R, Berrie, E, Becker, S, Lambe, T, Hill, A, Ewer, K, Gilbert, S